Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zai Lab Ltd (ZLAB) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zai Lab Ltd. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1704292.
Total stock buying since 2021: $988,211.
Total stock sales since 2021: $167,209,231.
Total stock option exercises since 2021: $8,562,528.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 1,731 | $32,733 | 269,036 | $5,177,305 | 609,093 | $577,459 |
| 2025 | 10,000 | $289,100 | 816,035 | $26,462,561 | 1,478,699 | $1,078,749 |
| 2024 | 6,000 | $126,688 | 145,768 | $2,920,733 | 254,859 | $796,593 |
| 2023 | 9,000 | $254,250 | 25,044 | $994,518 | 492,175 | $3,086,501 |
| 2022 | 0 | $0 | 4,780 | $227,205 | 9,804 | $5,562 |
| 2021 | 4,000 | $285,440 | 854,069 | $131,426,909 | 604,444 | $3,017,664 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-02 | Chen Yajing (Chief Financial Officer) | Sale | 519 | 16.15 | 8,382 |
| 2024-04-02 | Reinhart Harald (See Remarks) | Sale | 1,773 | 16.15 | 28,635 |
| 2024-04-02 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Sale | 885 | 16.15 | 14,293 |
| 2024-04-02 | Du Ying (Chairperson & CEO) | Sale | 5,787 | 16.15 | 93,465 |
| 2024-04-01 | Chen Yajing (Chief Financial Officer) | Option Ex | 1,500 | 16.72 | 25,080 |
| 2024-04-01 | Reinhart Harald (See Remarks) | Option Ex | 4,348 | 16.72 | 72,698 |
| 2024-04-01 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 3,501 | 16.72 | 58,536 |
| 2024-04-01 | Du Ying (Chairperson & CEO) | Option Ex | 14,200 | 16.72 | 237,423 |
| 2024-03-15 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Sale | 10,000 | 18.71 | 187,130 |
| 2024-03-15 | Amado Rafael (See Remarks) | Sale | 2,544 | 18.86 | 47,979 |
| 2024-03-01 | Smiley Joshua L (See Remarks) | Buy | 3,000 | 20.83 | 62,489 |
| 2024-01-03 | Reinhart Harald (See Remarks) | Sale | 4,803 | 26.12 | 125,463 |
| 2024-01-03 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Sale | 4,803 | 26.12 | 125,463 |
| 2024-01-03 | Du Ying (Chairperson & CEO) | Sale | 8,380 | 26.12 | 218,902 |
| 2024-01-02 | Amado Rafael (See Remarks) | Sale | 19,363 | 26.30 | 509,169 |
| 2024-01-01 | Reinhart Harald (See Remarks) | Option Ex | 17,548 | .00 | 0 |
| 2024-01-01 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 17,548 | .00 | 0 |
| 2024-01-01 | Du Ying (Chairperson & CEO) | Option Ex | 31,587 | .00 | 0 |
| 2023-12-29 | Amado Rafael (See Remarks) | Option Ex | 42,000 | .00 | 0 |
| 2023-12-14 | Smiley Joshua L (See Remarks) | Buy | 4,000 | 29.90 | 119,600 |
| 2023-11-16 | Smiley Joshua L (See Remarks) | Buy | 5,000 | 26.93 | 134,650 |
| 2023-11-02 | Chen Yajing (Chief Financial Officer) | Sale | 165 | 25.23 | 4,162 |
| 2023-11-01 | Chen Yajing (Chief Financial Officer) | Option Ex | 500 | .00 | 0 |
| 2023-09-29 | Chen Yajing (Chief Financial Officer) | Option Ex | 920 | .00 | 0 |
| 2023-08-17 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 4,850 | .00 | 0 |
| 2023-08-15 | Smiley Joshua L (See Remarks) | Option Ex | 15,900 | .00 | 0 |
| 2023-06-23 | Reinhart Harald (See Remarks) | Option Ex | 18,250 | 25.30 | 461,725 |
| 2023-06-23 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 14,600 | 25.30 | 369,380 |
| 2023-06-23 | Du Ying (Chairperson & CEO) | Option Ex | 58,800 | 25.30 | 1,487,640 |
| 2023-04-03 | Cho William Ki Chul (Chief Financial Officer) | Option Ex | 2,827 | .00 | 0 |
| 2023-03-31 | Reinhart Harald (See Remarks) | Option Ex | 4,348 | 33.26 | 144,614 |
| 2023-03-31 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 3,500 | 33.26 | 116,410 |
| 2023-03-31 | Du Ying (Chairperson & CEO) | Option Ex | 14,200 | 33.26 | 472,292 |
| 2023-03-06 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Sale | 7,965 | 40.55 | 322,980 |
| 2023-03-06 | Du Ying (Chairperson & CEO) | Option Ex | 300,000 | .00 | 0 |
| 2023-03-03 | Reinhart Harald (See Remarks) | Sale | 11,480 | 40.00 | 459,200 |
| 2023-03-03 | Reinhart Harald (See Remarks) | Option Ex | 11,480 | 3.00 | 34,440 |
| 2023-03-03 | Lis William (Director) | Sale | 5,434 | 38.31 | 208,176 |
| 2022-11-15 | Reinhart Harald (See Remarks) | Sale | 1,854 | 40.02 | 74,187 |
| 2022-11-15 | Reinhart Harald (See Remarks) | Option Ex | 1,854 | 3.00 | 5,562 |
| 2022-04-01 | Sandler Alan B. (Head of Global Dev., Oncology) | Option Ex | 1,060 | .00 | 0 |
| 2022-04-01 | Cho William Ki Chul (Chief Financial Officer) | Option Ex | 920 | .00 | 0 |
| 2022-04-01 | Liang Yi (CCO & President, Greater China) | Option Ex | 730 | .00 | 0 |
| 2022-04-01 | Reinhart Harald (See Remarks) | Option Ex | 1,010 | .00 | 0 |
| 2022-04-01 | Edmondson Frazor Titus Iii (Chief Legal Officer) | Option Ex | 830 | .00 | 0 |
| 2022-04-01 | Du Ying (Chairwoman & CEO) | Option Ex | 3,400 | .00 | 0 |
| 2022-02-04 | Diekman John D | Sale | 1,000 | 50.17 | 50,170 |
| 2022-01-20 | Lis William | Sale | 1,926 | 53.40 | 102,848 |
| 2021-12-08 | Wirth Peter | Buy | 4,000 | 71.36 | 285,440 |
| 2021-11-05 | Diekman John D | Sale | 1,000 | 91.65 | 91,650 |
| 2021-10-28 | Fu Tao (President & COO) | Sale | 10,000 | 104.81 | 1,048,100 |
| 2021-10-14 | Fu Tao (President & COO) | Sale | 10,000 | 102.79 | 1,027,870 |
| 2021-09-30 | Fu Tao (President & COO) | Sale | 10,000 | 107.25 | 1,072,450 |
| 2021-09-15 | Fu Tao (President & COO) | Sale | 10,000 | 131.65 | 1,292,657 |
| 2021-09-15 | Fu Tao (President & COO) | Option Ex | 10,000 | 18.92 | 189,200 |
| 2021-09-09 | Reinhart Harald (Chief Medical Officer) | Sale | 10,000 | 142.02 | 1,420,170 |
| 2021-09-09 | Reinhart Harald (Chief Medical Officer) | Option Ex | 10,000 | 3.00 | 30,000 |
| 2021-09-07 | Reinhart Harald (Chief Medical Officer) | Sale | 10,000 | 148.75 | 1,487,450 |
| 2021-09-07 | Reinhart Harald (Chief Medical Officer) | Option Ex | 10,000 | 3.00 | 30,000 |
| 2021-09-07 | Du Ying (Chairwoman & CEO) | Sale | 29,785 | 149.07 | 4,440,139 |
| 2021-09-03 | Du Ying (Chairwoman & CEO) | Sale | 24,145 | 145.26 | 3,507,254 |
| 2021-09-02 | Du Ying (Chairwoman & CEO) | Sale | 28,738 | 146.17 | 4,200,633 |
| 2021-09-01 | Du Ying (Chairwoman & CEO) | Sale | 28,443 | 146.76 | 4,174,209 |
| 2021-09-01 | Du Ying (Chairwoman & CEO) | Option Ex | 111,111 | .60 | 66,666 |
| 2021-08-25 | Fu Tao (President & COO) | Sale | 10,000 | 143.22 | 1,432,250 |
| 2021-08-25 | Fu Tao (President & COO) | Option Ex | 10,000 | 18.92 | 189,200 |
| 2021-08-24 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 143.36 | 1,146,880 |
| 2021-08-24 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 17.99 | 143,920 |
| 2021-08-23 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 135.00 | 1,080,000 |
| 2021-08-23 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 17.99 | 143,920 |
| 2021-08-05 | Diekman John D | Sale | 1,000 | 149.50 | 149,500 |
| 2021-08-03 | Du Ying (Chairwoman & CEO) | Sale | 26,217 | 145.46 | 3,813,419 |
| 2021-08-02 | Du Ying (Chairwoman & CEO) | Sale | 84,894 | 142.91 | 12,132,456 |
| 2021-08-02 | Du Ying (Chairwoman & CEO) | Option Ex | 111,111 | .60 | 66,666 |
| 2021-07-15 | Fu Tao (President & COO) | Sale | 10,000 | 172.73 | 1,727,280 |
| 2021-07-15 | Fu Tao (President & COO) | Option Ex | 10,000 | 18.92 | 189,200 |
| 2021-07-14 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 169.11 | 1,352,880 |
| 2021-07-14 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 18.00 | 143,960 |
| 2021-07-13 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 169.92 | 1,359,360 |
| 2021-07-13 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 18.00 | 144,000 |
| 2021-07-02 | Du Ying (Chairwoman & CEO) | Sale | 27,253 | 176.28 | 4,804,158 |
| 2021-07-01 | Du Ying (Chairwoman & CEO) | Sale | 83,858 | 176.57 | 14,807,058 |
| 2021-07-01 | Du Ying (Chairwoman & CEO) | Option Ex | 111,111 | .60 | 66,666 |
| 2021-06-17 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 161.64 | 1,293,120 |
| 2021-06-17 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 18.00 | 144,000 |
| 2021-06-16 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 162.71 | 1,301,680 |
| 2021-06-16 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 20.90 | 167,200 |
| 2021-06-02 | Cho William Ki Chul (Chief Financial Officer) | Sale | 1,416 | 180.69 | 255,857 |
| 2021-06-02 | Du Ying (Chairwoman & CEO) | Sale | 9,463 | 177.80 | 1,682,549 |
| 2021-06-01 | Cho William Ki Chul (Chief Financial Officer) | Sale | 8,584 | 180.12 | 1,546,150 |
| 2021-06-01 | Du Ying (Chairwoman & CEO) | Sale | 101,648 | 176.30 | 17,920,542 |
| 2021-06-01 | Du Ying (Chairwoman & CEO) | Option Ex | 111,111 | .60 | 66,666 |
| 2021-05-26 | Fu Tao (President & COO) | Sale | 10,000 | 159.88 | 1,598,750 |
| 2021-05-26 | Fu Tao (President & COO) | Option Ex | 10,000 | 18.92 | 189,200 |
| 2021-05-25 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 161.66 | 1,293,280 |
| 2021-05-25 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 20.90 | 167,200 |
| 2021-05-24 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 162.37 | 1,298,960 |
| 2021-05-24 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 20.90 | 167,200 |
| 2021-05-05 | Diekman John D | Sale | 1,000 | 153.62 | 153,620 |
| 2021-05-04 | Du Ying (Chairwoman & CEO) | Sale | 48,947 | 162.49 | 7,953,593 |
| 2021-05-03 | Du Ying (Chairwoman & CEO) | Sale | 62,164 | 163.16 | 10,142,802 |
| 2021-04-21 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 161.99 | 1,295,920 |
| 2021-04-21 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 20.90 | 167,200 |
| 2021-04-20 | Reinhart Harald (Chief Medical Officer) | Sale | 8,000 | 150.20 | 1,201,600 |
| 2021-04-20 | Reinhart Harald (Chief Medical Officer) | Option Ex | 8,000 | 20.90 | 167,200 |
| 2021-04-07 | Du Ying (Chairwoman & CEO) | Sale | 21,936 | 133.47 | 2,927,732 |
| 2021-04-06 | Du Ying (Chairwoman & CEO) | Sale | 38,392 | 126.37 | 4,851,635 |
| 2021-04-05 | Du Ying (Chairwoman & CEO) | Sale | 50,784 | 128.28 | 6,514,723 |
| 2021-03-26 | Fu Tao (President & COO) | Option Ex | 20,000 | 18.92 | 378,400 |
| 2021-03-12 | Chen Kai-xian (Director) | Sale | 4,302 | 142.53 | 613,164 |
Insider trading activities including stock purchases, stock sales, and option exercises of ZLAB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zai Lab Ltd (symbol ZLAB, CIK number 1704292) see the Securities and Exchange Commission (SEC) website.